Kieron E. Wesson
26Patents
9h-index
18Co-inventors
68Inventor score
Filing activity: Dec 3, 2003 → Mar 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7968746B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 41 | Active |
| US8106223B2 | Process for the production of alpha-tocotrienol and derivatives | Chemistry; Metallurgy | 41 | Active |
| US8716486B2 | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases | Chemistry; Metallurgy | 36 | Active |
| US8716527B2 | 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases | Chemistry; Metallurgy | 35 | Active |
| US8575369B2 | Process for the production of alpha-tocotrienol and derivatives | Chemistry; Metallurgy | 33 | Active |
| US8519001B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 27 | Active |
| US9278085B2 | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers | Chemistry; Metallurgy | 19 | Active |
| US8952071B2 | (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 18 | Active |
| US9169196B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 10 | Active |
| US7479502B2 | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors | Chemistry; Metallurgy | 9 | Expired |
| US9486435B2 | (Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 7 | Active |
| US8299110B2 | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9073873B2 | 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases | Chemistry; Metallurgy | 4 | Active |
| US8415328B2 | Factor VIIa inhibitor | Human Necessities | 4 | Active |
| US10189830B2 | Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders | Chemistry; Metallurgy | 3 | Active |
| US9932286B2 | Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers | Chemistry; Metallurgy | 3 | Active |
| US10251847B2 | Polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Chemistry; Metallurgy | 3 | Active |
| US9090576B2 | 2-substituted-p-quinone derivatives for treatment of oxidative stress diseases | Chemistry; Metallurgy | 3 | Active |
| US8778625B2 | 2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors | Chemistry; Metallurgy | 2 | Active |
| US11840497B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 0 | Active |
| US9546132B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 0 | Active |
| US11938101B2 | Polymorphic forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide | Chemistry; Metallurgy | 0 | Active |
| US9162986B2 | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10167251B2 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 0 | Active |
| US10968166B2 | 4-(P-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.